Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-03-23

Clinical Trial Update: Botanical/Drug Interactions in HIV: Glucuronidation [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update from NCCIH investigating botanical-drug interactions focused on glucuronidation in HIV-seronegative individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: HIV Seronegativity | Phase 1 | Status: COMPLETED